Human cardiomyocytes hCM hiPSC-CM cardiomyocytes Human

Human iPSC Cardiomyocytes

Human cardiomyocytes derived from iPS cells for preclinical drug studies

Healthy human heart cells are very rare and only available in very small quantities for obvious reasons of accessibility. Human cardiomyocytes derived from induced pluripotent stem cells (hiPSC-CM) allow to access human ventricular-like myocytes more easily. Due to their origin, these cells present the same functional and electrophysiological characteristics as human cardiomyocytes and offer a good alternative to ex vivo and in vivo models for drug development.

Human iPSC cardiomyocytes & cardiac safety studies

Human cardiomyocytes derived from iPS cells provide a good solution to study the repercussion of ion channels effects on cardiac electrical activity during preclinical studies. This human in vitro model can be used to evaluate the cardiac safety of newly developed drugs and is currently validated by CIPA initiative for cardiac preclinical safety assessment.

What is shown?

To measure the effects of newly developed drugs on cardiac pharmacology, we study their action potential, i.e. we measure ion movements through the different transmembrane ionic channels. The modification of the shape of the action potential gives information about ion channel effects.

Cardiac Electrophysiology (MEA), Viability and Contractility (Impedance) signals

Impedance measurements

Healthy human heart cells are very rare and only available in very small quantities for obvious reasons of accessibility. Human cardiomyocytes derived from induced pluripotent stem cells (hiPSC-CM) allow to access human ventricular-​like myocytes more easily. Due to their origin, these cells present the same functional and electrophysiological characteristics as human cardiomyocytes and offer a good alternative to ex vivo and in vivo models for drug development.

Microelectrode array

MicroElectrode Array (MEA) recordings are a non-invasive way to measure integrated ion channel activity. The MEA system provides ECG-like results and detects modifications in beat rate, pro-arrhythmic events and other adverse effects.

Technique

  • xCELLigence RTCA Cardio ECR platform

Study model

  • Human IPSc derived cardiomyocytes
  • 48 wells plate format
  • Simultaneous recording of MEA and impedance signals on the entire plate
  •  Disease Models (Option)
    • Brugada Syndrome
    • Dilated Cardiomyopathy
    • Hypertrophic Cardiomyopathy
    • Catecholaminergic Polymorphic Ventricular Tachycardia

Protocol

  • 1 negative control (DMSO 0.1%)
  • 2 or 3 positive controls (1 concentration)
  • Compounds: several options from 1 compound (6 concentrations, n=6) up to 9 compounds (1 concentration, n=4)
  • Short-term and long-term exposure (up to 48 to 72h)

Measured parameters

  • Cell viability: Cell Index
  • Electrophysiology (MEA)
    • Firing rate
    • FPD
    • FPDc (Fredericia)
    • Spike amplitude
  • Contraction (Impedance)
    • Amplitude of contraction
    • Beat rate
    • Beating period
    • Individual beat duration (IBD10, 50, 90)
    • Proarrhythmic events (BRI)
Mea-impedance

Reference compounds

  • Nifedipine
  • E-4031
  • Pentamidine

Results

  • Stability of recorded parameters in control conditions and reproductibility between plates

Typical effects of DMSO 0.1% on Beat rate.

Nifedipine (Low TdP risk)

Nifedipine

Typical effects of Nifedipine on the amplitude of contraction.

Pentamidine (long-term exposure)

Pentamidine

Typical effects of Pentamidine on impedance signal and FPDc.

Request a quote

    I accept that the information entered in this contact form is used and processed so that PhysioStim can contact me to answer my request.(required)

    Additional tests according to PhysioStim scientist’s expertise

    Isolated Perfused Heart Langendorf

    Isolated perfused heart

    hERG Assays Manual Patch Clamp

    hERG assays

    PhysioStim Sodium Channel assays

    Sodium channel assays

    Calcium channel CaV1.2

    Calcium channel assays

    PhysioStim Potassium Channel assays

    Other Potassium channel assays

    Need help with your preclinical safety studies?

    contact us